Clinical effectiveness of a systematic “pill-in-the-pocket” approach for the management of paroxysmal atrial fibrillation-Reference-Cited by-同舟云学术

Clinical effectiveness of a systematic “pill-in-the-pocket” approach for the management of paroxysmal atrial fibrillation

Published:2018-01 Issue:1 Volume:15 Page:9-16
ISSN:1547-5271
Container-title:Heart Rhythm
language:en
Short-container-title:Heart Rhythm

Author:

Andrade Jason G.,MacGillivray Jenny,Macle Laurent,Yao Ren Jie Robert,Bennett Matthew,Fordyce Christopher B.,Hawkins Nathaniel,Krahn Andrew,Jue John,Ramanathan Krishnan,Tsang Teresa,Gin Ken,Deyell Marc W.

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference22 articles.

1. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms;Andrade;Circ Res,2014

2. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK;Stewart;Heart,2004

3. Economic burden and co-morbidities of atrial fibrillation in a privately insured population;Wu;Curr Med Res Opin,2005

4. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States;Coyne;Value Health,2006

5. Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care;Dell’Orfano;Am J Cardiol,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial Fibrillation in the Emergency Department: More Than “Meet ‘Em, Treat ‘Em, and Street ‘Em”;Canadian Journal of Cardiology;2024-09

2. Pill-in-the-Pocket for Paroxysmal Atrial Fibrillation: A Review and Case Study;The Journal for Nurse Practitioners;2024-07

3. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

4. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01

5. Safety of Pill-in-the-Pocket Class 1C Antiarrhythmic Drugs for Atrial Fibrillation;JACC: Clinical Electrophysiology;2022-12